Standard BioTools Inc (LAB) last year’s performance of -58.10% is a clear signal for an entertaining trading season.
On Tuesday, Standard BioTools Inc (NASDAQ: LAB) was -7.83% drop from the session before settling in for the closing price of $1.15. A 52-week range